HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.0050
Year range
$0.0050 - $0.035
Market cap
285.35K CAD
Avg Volume
41.60K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change | 
|---|---|---|
| Revenue | — | — | 
| Operating expense | 4.00K | -97.46% | 
| Net income | -11.24K | 93.67% | 
| Net profit margin | — | — | 
| Earnings per share | — | — | 
| EBITDA | 11.55K | 109.42% | 
| Effective tax rate | — | — | 
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change | 
|---|---|---|
| Cash and short-term investments | 6.68K | -40.38% | 
| Total assets | 6.68K | -99.30% | 
| Total liabilities | 903.22K | -3.03% | 
| Total equity | -896.54K | — | 
| Shares outstanding | 57.07M | — | 
| Price to book | -0.25 | — | 
| Return on assets | -77.13% | — | 
| Return on capital | 1.24% | — | 
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change | 
|---|---|---|
| Net income | -11.24K | 93.67% | 
| Cash from operations | -12.55K | 50.35% | 
| Cash from investing | — | — | 
| Cash from financing | 0.00 | -100.00% | 
| Net change in cash | -12.55K | -22.16% | 
| Free cash flow | -5.43K | 65.83% | 
About
Headquarters
Website
